[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:fabry-disease":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":91,"states":96},"Fabry Disease",13,11,[8,16,23,30,36,42,48,54,60,66,72,78,85],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06328608","A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease",[12],"Phase 2\u002FPhase 3","RECRUITING","2026-08-26T02:15:57.572488Z","2026-05-05T02:43:29.586065Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06904261","A Study of Migalastat in Pediatric Subjects (2 to \u003C12 Yrs) With Fabry Disease and Amenable GLA Variants",[20],"Phase 3","2026-08-26T02:18:35.425468Z","2026-05-05T02:43:29.077075Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT06858397","A proof-of Concept Study to Assess Safety and Tolerability of HM15421\u002FGC1134A in Patients With Fabry Disease",[27],"Phase 1\u002FPhase 2","2026-08-26T02:17:38.215063Z","2026-05-05T02:43:29.042330Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT06270316","Safety, PK\u002FPD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease",[27],"2026-08-26T02:17:21.315591Z","2026-05-05T02:43:28.317681Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT06941025","Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding",[],"2026-08-26T02:16:59.895916Z","2026-05-13T02:55:06.592378Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06906367","A Study of Patients With Fabry Disease (US Specific)",[],"2026-08-26T02:18:27.904411Z","2026-05-13T02:55:06.590359Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT06663358","A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients",[],"2026-08-26T02:17:03.534765Z","2026-05-13T02:55:06.560994Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT04252066","A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding",[],"2026-08-26T02:18:26.932189Z","2026-05-13T02:55:06.244644Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT01581424","Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study",[],"2026-08-26T02:18:24.494016Z","2026-05-13T02:55:06.080695Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT00196742","Fabry Disease Registry & Pregnancy Sub-registry",[],"2026-08-26T02:18:21.216897Z","2026-05-13T02:55:06.032092Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT06610019","Cardiovascular Multimodality Imaging Study",[],"2026-08-26T02:17:05.997056Z","2026-05-13T02:55:06.556690Z",{"nct_id":79,"title":80,"phases":81,"status":82,"updated_at":83,"content_modified":84},"NCT05039866","Long-Term Follow-up of Subjects Who Were Treated With ST-920",[],"ENROLLING_BY_INVITATION","2026-08-03T03:40:23.064418Z","2026-06-16T05:54:07.972937Z",{"nct_id":86,"title":87,"phases":88,"status":82,"updated_at":89,"content_modified":90},"NCT05368038","ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program",[],"2026-08-26T02:18:52.966503Z","2026-06-16T05:54:08.030731Z",[92],{"biomarker":93,"count":94,"slug":95},"GALACTOSIDASE, ALPHA",5,"galactosidase-alpha",[97,101,105,109,112,115,118,122,125,129,132],{"state":98,"count":99,"slug":100},"Virginia",8,"virginia",{"state":102,"count":103,"slug":104},"Georgia",7,"georgia",{"state":106,"count":107,"slug":108},"Minnesota",6,"minnesota",{"state":110,"count":107,"slug":111},"New York","new-york",{"state":113,"count":107,"slug":114},"Pennsylvania","pennsylvania",{"state":116,"count":94,"slug":117},"Ohio","ohio",{"state":119,"count":120,"slug":121},"Alabama",4,"alabama",{"state":123,"count":120,"slug":124},"Iowa","iowa",{"state":126,"count":127,"slug":128},"California",3,"california",{"state":130,"count":127,"slug":131},"Illinois","illinois",{"state":133,"count":127,"slug":134},"Utah","utah"]